AU2742799A - Voacamine as anti-malarial agent and anti-malarial agent containing voacamine - Google Patents

Voacamine as anti-malarial agent and anti-malarial agent containing voacamine

Info

Publication number
AU2742799A
AU2742799A AU27427/99A AU2742799A AU2742799A AU 2742799 A AU2742799 A AU 2742799A AU 27427/99 A AU27427/99 A AU 27427/99A AU 2742799 A AU2742799 A AU 2742799A AU 2742799 A AU2742799 A AU 2742799A
Authority
AU
Australia
Prior art keywords
voacamine
malarial agent
malarial
agent containing
containing voacamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27427/99A
Inventor
Guiseppe Bertelli Motta
Silvio Rossi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MILLENIA HOPE Inc
Original Assignee
MILLENIA HOPE Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MILLENIA HOPE Inc filed Critical MILLENIA HOPE Inc
Publication of AU2742799A publication Critical patent/AU2742799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU27427/99A 1998-03-26 1999-03-25 Voacamine as anti-malarial agent and anti-malarial agent containing voacamine Abandoned AU2742799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITTO98A0264 1998-03-26
IT98TO000264A ITTO980264A1 (en) 1998-03-26 1998-03-26 APPLICATION OF A NON-QUATERNARY BASIC EXTRACT OF FUCHSIAEFOLIA PESCHIERA WITH ANTI-MALARICA ACTIVITY
PCT/IB1999/000524 WO1999048501A1 (en) 1998-03-26 1999-03-25 Voacamine as anti-malarial agent and anti-malarial agent containing voacamine

Publications (1)

Publication Number Publication Date
AU2742799A true AU2742799A (en) 1999-10-18

Family

ID=11416637

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27427/99A Abandoned AU2742799A (en) 1998-03-26 1999-03-25 Voacamine as anti-malarial agent and anti-malarial agent containing voacamine

Country Status (10)

Country Link
EP (1) EP1067938A1 (en)
JP (1) JP2002507570A (en)
AP (1) AP2000001926A0 (en)
AU (1) AU2742799A (en)
BR (1) BR9909153A (en)
CA (1) CA2325879A1 (en)
IT (1) ITTO980264A1 (en)
OA (1) OA11491A (en)
WO (1) WO1999048501A1 (en)
ZA (1) ZA200006020B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2812199A1 (en) * 2000-07-31 2002-02-01 Maximun Frederic Yanze Effervescent antimalarial compositions containing chloroquine, optionally other active agents, effervescent couple and taste modifiers, is dissolved in water to give a pleasant tasting solution for oral administration
EP1491197A1 (en) * 2003-06-26 2004-12-29 Bertelli Motta, Guiseppe Pharmaceutical composition comprising voacamine for the stimulation and modulation of the human immunologic system
US20070232588A1 (en) * 2004-09-15 2007-10-04 Leonard Stella Anti-parasitic and/or anti-viral and/or anti-microbial compositions
US20070032460A1 (en) * 2005-08-04 2007-02-08 Leonard Stella Use of voacamine and related compounds in the treatment of malaria
CA2624750C (en) 2005-10-04 2012-01-03 The Director General, Defence Research And Development Organisation Anti-malarial compound isolated from gomphostemma niveum
EP1958638A1 (en) 2007-02-14 2008-08-20 Polichem S.A. Use of chitosans to increase nail growth rate
WO2013081374A1 (en) 2011-11-28 2013-06-06 연세대학교 산학협력단 Pharmaceutical composition for inhibiting angiogenesis containing plant-derived natural compound
JP2016508979A (en) * 2012-12-20 2016-03-24 デメレックス， インコーポレイテッド Substituted norbogaine
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
CA3138100A1 (en) 2019-04-17 2020-10-22 Compass Pathfinder Limited Treatment of depression and other various disorders with psilocybin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2823204A (en) * 1956-03-30 1958-02-11 Gobey Lab Alkaloids of voacanga

Also Published As

Publication number Publication date
ITTO980264A1 (en) 1999-09-26
BR9909153A (en) 2000-11-14
WO1999048501A9 (en) 2000-03-16
JP2002507570A (en) 2002-03-12
CA2325879A1 (en) 1999-09-30
OA11491A (en) 2004-05-07
AP2000001926A0 (en) 2000-09-30
EP1067938A1 (en) 2001-01-17
ZA200006020B (en) 2001-06-25
WO1999048501A1 (en) 1999-09-30

Similar Documents

Publication Publication Date Title
AU7989400A (en) Compounds and methods
AU3215500A (en) Compounds and methods
AU4198299A (en) Compounds and uses thereof
AU2349399A (en) R-lansoprazole compositions and methods
AU2660900A (en) 4-haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclyl-pyrimidines and their use as repellents
AU5565099A (en) Pharmaceutical compositions and methods for use
AU5161399A (en) N-benzocycloalkyl-amide derivatives and their use as medicaments
AU2460100A (en) Masking agent
AU1403501A (en) Novel composition and use
AU2001292047A1 (en) Composition containing an azaphthalocyanine and use
AUPP433398A0 (en) Compounds and processes
AU2742799A (en) Voacamine as anti-malarial agent and anti-malarial agent containing voacamine
AU7853700A (en) Foams and compositions containing these foams
AU7277798A (en) Use of sialyl galactosides and related compounds as anti-angiogenic agents
AU1554301A (en) Radioprotecting agent
AU1152601A (en) Compositions and their use
AU6519198A (en) Melaninization inhibitor, skin-care preparation, and bath agent
AU2333099A (en) Aryloxyanilides and related compounds
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU5176299A (en) Compound, composition and use
AU768217C (en) 2-methylpropionic acid derivatives and medicinal compositions containing the same
AU7308300A (en) Agents for reducing cholesterol-uptake and liquid-uptake
AUPO982097A0 (en) Methods and compositions for use therein
AU2880699A (en) Pharmaceutical compositions and methods for use
AU1046799A (en) Compound, composition and use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase